Related Experiment Video
Updated: Jun 11, 2025
06:40
Cecal Ligation and Puncture-induced Sepsis as a Model To Study Autophagy in Mice
Published on: February 9, 2014
28.3K
MicroRNAs in Sepsis.
Asimina Valsamaki1, Vasileios Vazgiourakis1, Konstantinos Mantzarlis1
1Intensive Care Unit, Faculty of Medicine, University of Thessaly, 41500 Larissa, Greece.
Biomedicines
|September 28, 2024
Summary
MicroRNAs (miRs) show promise as sensitive and specific biomarkers for sepsis diagnosis and prognosis. These non-coding RNAs offer insights into sepsis mechanisms and potential therapeutic targets.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Sepsis is a severe inflammatory condition caused by infections.
- Current biomarkers for sepsis lack specificity.
- MicroRNAs (miRs) are non-coding RNAs involved in cellular homeostasis and disease, including sepsis.
Purpose of the Study:
- To review prominent miRs identified in sepsis.
- To assess the utility of miRs in sepsis diagnosis, prognosis, and classification.
- To explore miRs as potential screening tools for specific septic parameters.
Main Methods:
- Literature overview of studies identifying miRs in septic conditions.
- Analysis of miRs involved in inflammatory and immune pathways.
- Investigation of miRs for correlation with infection type, affected organs, and immune pathways (e.g., NF-kB, STAT/JACK).
Main Results:
- Several miRs, including MIR-146a, MIR-155, MIR-181b, MIR-223-5p, MIR-494-3p, MIR-2055b, MIR-150, and MIR-143, are highlighted as potential diagnostic and prognostic tools.
- miRs can be used in panels to specify infection type, affected organs, and immune pathways.
- Co-screening of miRs with long non-coding RNAs (LNCs) is suggested for understanding sepsis progression.
Conclusions:
- miRs offer enhanced specificity and sensitivity compared to traditional biomarkers for sepsis.
- miRs are stable, easy to use, and provide valuable insights into sepsis molecular basis and causality.
- miRs hold potential for improved sepsis diagnosis, prognosis, classification, and therapeutic guidance.
